Breaking News
Investing Pro 0
💎 Access the Market Tools Trusted by Thousands of Investors Get Started
Close

Novo Nordisk A/S (NVON)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
1,615.420 0.000    0.00%
05:26:44 - Closed. Currency in MXN ( Disclaimer )
  • Volume: 82
  • Bid/Ask: 1,550.110 / 1,897.970
  • Day's Range: 1,615.420 - 1,625.000
Type:  Equity
Market:  Mexico
ISIN:  US6701002056 
Novo Nordisk ADR 1,615.420 0.000 0.00%

NVON Financial Summary

 
A brief financial summary of Novo Nordisk A/S as well as the most significant critical numbers from each of its financial reports. In addition, some financial ratios derived from these reports are featured. Users can opt to see 4 periods of either annual or quarterly information.

Novo Nordisk A/S reported earnings results for the second quarter and six months ended June 30, 2023. For the second quarter, the company reported sales was DKK 54,300 million compared to DKK 41,265 million a year ago. Net income was DKK 19,428 million compared to DKK 13,318 million a year ago. Basic earnings per share from continuing operations was DKK 4.325 compared to DKK 2.935 a year ago. Diluted earnings per share from continuing operations was DKK 4.315 compared to DKK 2.93 a year ago.For the six months, sales was DKK 107,667 million compared to DKK 83,296 million a year ago. Net income was DKK 39,242 million compared to DKK 27,528 million a year ago. Basic earnings per share from continuing operations was DKK 8.73 compared to DKK 6.055 a year ago. Diluted earnings per share from continuing operations was DKK 8.705 compared to DKK 6.04 a year ago.

AnnualQuarterly  
InvestingPro Advanced Financial Summary
TTM = Trailing Twelve Months
MRQ = Most Recent Quarter

NVON Income Statement

Gross margin TTM 84.35%
Operating margin TTM 43.2%
Net Profit margin TTM 33.4%
Return on Investment TTM 64.41%
 Total Revenue  Net Income
Period Ending: Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022
Total Revenue 54300 53367 48092 45566
Gross Profit 46444 45185 39830 38366
Operating Income 23888 25007 17898 20184
Net Income 19428 19814 13592 14405

NVON Balance Sheet

Quick Ratio MRQ 0.62
Current Ratio MRQ 0.88
LT Debt to Equity MRQ 21.46%
Total Debt to Equity MRQ 28.41%
 Total Assets  Total Liabilities
Period Ending: Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022
Total Assets 280753 250025 241257 242836
Total Liabilities 190280 170151 157771 166156
Total Equity 90473 79874 83486 76680

NVON Cash Flow Statement

Cash Flow/Share TTM 20.02
Revenue/Share TTM 44.91
Operating Cash Flow  18.25%
 Cash  Net Change in Cash
Period Ending: Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022
Period Length: 0 Months 0 Months 0 Months 0 Months
Cash From Operating Activities 28577 29814 7101 24239
Cash From Investing Activities -9285 -6647 -13850 -4961
Cash From Financing Activities -12589 -20621 -7668 -14563
Net Change in Cash 6638 2283 -15261 5158
* In Millions of DKK (except for per share items)
InvestingPro
Go to Dashboard InvestingPro

Unlock access to over 1000 metrics with InvestingPro

View advanced insights on financial statements, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.

 
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

NVO Comments

Write your thoughts about Novo Nordisk A/S
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email